These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 3121520)

  • 1. Protective effect of an outer membrane vaccine against Pseudomonas aeruginosa infection.
    von Specht BU; Strigl G; Ehret W; Brendel W
    Infection; 1987; 15(5):408-12. PubMed ID: 3121520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa.
    Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM
    J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outer membrane proteins of Pseudomonas aeruginosa as vaccine candidates.
    von Specht B; Knapp B; Hungerer K; Lücking C; Schmitt A; Domdey H
    J Biotechnol; 1996 Jan; 44(1-3):145-53. PubMed ID: 8717398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine against heterologous immunotype strains in a burned mouse model.
    Matthews-Greer JM; Gilleland HE
    J Infect Dis; 1987 Jun; 155(6):1282-91. PubMed ID: 3033095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization of burn-patients with a Pseudomonas aeruginosa outer membrane protein vaccine elicits antibodies with protective efficacy.
    Lee NG; Jung SB; Ahn BY; Kim YH; Kim JJ; Kim DK; Kim IS; Yoon SM; Nam SW; Kim HS; Park WJ
    Vaccine; 2000 Mar; 18(18):1952-61. PubMed ID: 10699346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant
    Li P; Wang X; Sun X; Cimino J; Guan Z; Sun W
    Infect Immun; 2021 Oct; 89(11):e0039621. PubMed ID: 34310892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outer membrane protein F preparation of Pseudomonas aeruginosa as a vaccine against chronic pulmonary infection with heterologous immunotype strains in a rat model.
    Gilleland HE; Gilleland LB; Matthews-Greer JM
    Infect Immun; 1988 May; 56(5):1017-22. PubMed ID: 2833440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
    Zaidi TS; Priebe GP; Pier GB
    Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of immunosuppressed mice against translocation of Pseudomonas aeruginosa from the gut by oral immunization with recombinant Pseudomonas aeruginosa outer membrane protein I expressing Salmonella dublin.
    Toth A; Schödel F; Duchêne M; Massarrat K; Blum B; Schmitt A; Domdey H; von Specht BU
    Vaccine; 1994 Oct; 12(13):1215-21. PubMed ID: 7839727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of protective mAbs against Pseudomonas aeruginosa outer membrane protein I by C1q binding assay.
    Eckhardt A; Heiss MM; Ehret W; Permanetter W; Duchêne M; Domdey H; von Specht BU
    Zentralbl Bakteriol; 1991 Apr; 275(1):100-11. PubMed ID: 1930557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection.
    Gilleland HE; Gilleland LB; Staczek J; Harty RN; García-Sastre A; Palese P; Brennan FR; Hamilton WD; Bendahmane M; Beachy RN
    FEMS Immunol Med Microbiol; 2000 Apr; 27(4):291-7. PubMed ID: 10727884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an anti-adhesive vaccine for Pseudomonas aeruginosa targeting the C-terminal region of the pilin structural protein.
    Sheth HB; Glasier LM; Ellert NW; Cachia P; Kohn W; Lee KK; Paranchych W; Hodges RS; Irvin RT
    Biomed Pept Proteins Nucleic Acids; 1995; 1(3):141-8. PubMed ID: 9346845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against infection with Pseudomonas aeruginosa by passive transfer of monoclonal antibodies to lipopolysaccharides and outer membrane proteins.
    Sawada S; Suzuki M; Kawamura T; Fujinaga S; Masuho Y; Tomibe K
    J Infect Dis; 1984 Oct; 150(4):570-6. PubMed ID: 6436393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES; Lam JS
    FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a Protective Vaccine Against Lipopolysaccharide-Heterologous
    Liu C; Pan X; Xia B; Chen F; Jin Y; Bai F; Priebe G; Cheng Z; Jin S; Wu W
    Front Immunol; 2018; 9():1737. PubMed ID: 30093906
    [No Abstract]   [Full Text] [Related]  

  • 16. Outer membrane proteins of Pseudomonas aeruginosa as vaccine candidates.
    von Specht BU; Domdey H; Schödel F; Blum B; Lücking C; Knapp B; Muth G; Hungerer KD; Bröker M
    Behring Inst Mitt; 1994 Dec; (95):85-96. PubMed ID: 7538752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice.
    Gilleland HE; Parker MG; Matthews JM; Berg RD
    Infect Immun; 1984 Apr; 44(1):49-54. PubMed ID: 6323316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against experimental Pseudomonas aeruginosa infection by recombinant P. aeruginosa lipoprotein I expressed in Escherichia coli.
    Finke M; Duchêne M; Eckhardt A; Domdey H; von Specht BU
    Infect Immun; 1990 Jul; 58(7):2241-4. PubMed ID: 2114360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preservation of pulmonary function by an outer membrane protein F vaccine. A study in rats with chronic pulmonary infection caused by Pseudomonas aeruginosa.
    Fox CW; Campbell GD; Anderson WM; Zavecz JH; Gilleland LB; Gilleland HE
    Chest; 1994 May; 105(5):1545-50. PubMed ID: 8181349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective efficacy of recombinant exotoxin A--flagellin fusion protein against Pseudomonas aeruginosa infection.
    Farajnia S; Peerayeh SN; Tanomand A; Majidi J; Goudarzi G; Naghili B; Rahbarnia L
    Can J Microbiol; 2015 Jan; 61(1):60-4. PubMed ID: 25496361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.